INO-4800

INO-4800 · Inovio Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for INO-4800, covering 2022-07-18 to 2023-12-20. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure [Phase 2, Phase 3]

See pricing